DeepMed Research

SOCIEDADE BENEF ISRAELITABRAS HOSPITAL ALBERT EINSTEIN

🇧🇷Brazil

Country: 🇧🇷Brazil

Ownership: Private

Established: 1971-01-01

Employees: 10K

Market Cap: -

Website: https://www.einstein.br

Clinical Trials

Salivary SARS-CoV-2 Load of Covid-19 Patients After Oral Antimicrobial Solutions and Dentifrices

Not Applicable

Completed

Conditions: Corona Virus Infection

Interventions: Other: Colgate Periogard® mouthwash
Other: Colgate Total® Mouthwash
Other: Toothpaste with sodium monofluorophosphate
Other: Toothpaste with sodium fluoride and zinc
Other: Toothpaste with tin fluoride
Other: Colgate Peroxyl® mouthwash

First Posted Date: 2020-09-03

Last Posted Date: 2022-02-25

Lead Sponsor: Hospital Israelita Albert Einstein

Target Recruit Count: 202

Registration Number: NCT04537962

Locations: 🇧🇷
Hospital israelita Albert Einstein, Sao Paulo, Brazil

Evidence-Based Practice: Proposed Application of Facilitating Tools for Clinical Nurses

Not Applicable

Completed

Conditions: Evidence-Based Practice

Interventions: Behavioral: Educational Workshop
Behavioral: Educational Workshop plus J. H. N. EBP Guide Tools

First Posted Date: 2020-07-23

Last Posted Date: 2023-09-26

Lead Sponsor: Hospital Israelita Albert Einstein

Target Recruit Count: 29

Registration Number: NCT04483713

Locations: 🇧🇷
Hospital Israelita Albert Einstein, Sao Paulo, Brazil

Brazilian Registry for Clinical Presentation of Individuals With COVID-19 (SARS-Brazil)

Completed

Conditions: Covid19
SARS-CoV Infection

Interventions: Other: Non-hospitalization procedures
Other: Hospital admission

First Posted Date: 2020-07-21

Last Posted Date: 2023-03-09

Lead Sponsor: Hospital Israelita Albert Einstein

Target Recruit Count: 1587

Registration Number: NCT04479488

Locations: 🇧🇷
Hospital Estadual Jayme dos Santos Neves, Serra, Espirito Santo, Brazil
🇧🇷
Hospital Santa Rita de Cássia, Vitória, Espirito Santo, Brazil
🇧🇷
Fundação Educacional Lucas Machado, Belo Horizonte, Minas Gerais, Brazil

and more 11 locations

Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia

Phase 3

Completed

Conditions: Covid19

Interventions: Drug: Tofacitinib 10 mg
Drug: Placebo

First Posted Date: 2020-07-13

Last Posted Date: 2021-08-09

Lead Sponsor: Hospital Israelita Albert Einstein

Target Recruit Count: 289

Registration Number: NCT04469114

Locations: 🇧🇷
Beneficência Portuguesa, São Paulo, Brazil
🇧🇷
Centro de Pesquisa Clínica do Coração, Aracaju, Brazil
🇧🇷
Irmandade do Sr. Bom Jesus dos Passos da Santa Casa de Misericórdia de Bragança Paulista, Bragança Paulista, Brazil

and more 14 locations

Characterization of the Clinical-epidemiological Profile of Patients With SMA5q Types II and III: Observational Study

Completed

Conditions: Spinal Muscular Atrophy

Interventions: Drug: Nusinersen Injectable Product

First Posted Date: 2020-05-27

Last Posted Date: 2021-04-27

Lead Sponsor: Hospital Israelita Albert Einstein

Target Recruit Count: 155

Registration Number: NCT04404764

Locations: 🇧🇷
Universidade Federal de São Paulo, São Paulo, Brazil
🇧🇷
Universidade Federal de Minas Gerais - Hospital das Clínicas, Belo Horizonte, Brazil
🇧🇷
Hospital de Clínicas da Universidade Estadual de Campinas - Unicamp, Campinas, Brazil

and more 6 locations

Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses

Not Applicable

Conditions: Coronary Artery Disease

Interventions: Procedure: Robot Assisted Percutaneous Cardiovascular Intervention

First Posted Date: 2020-05-07

Last Posted Date: 2020-05-08

Lead Sponsor: Hospital Israelita Albert Einstein

Target Recruit Count: 10

Registration Number: NCT04379453

Locations: 🇧🇷
Hospital Israelita Albert Einstein, São Paulo, Brazil

Percutaneous Coronary Intervention Followed by Antiplatelet Monotherapy in the Setting of Acute Coronary Syndromes

Phase 3

Active, not recruiting

Conditions: Acute Coronary Syndrome

Interventions: Drug: Antiplatelet Monotherapy

First Posted Date: 2020-04-24

Last Posted Date: 2025-04-08

Lead Sponsor: Hospital Israelita Albert Einstein

Target Recruit Count: 3400

Registration Number: NCT04360720

Locations: 🇧🇷
Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil
🇧🇷
Acurácia Serviços Médicos, Rio Branco, Acre, Brazil
🇧🇷
Hospital Ana Nery, Salvador, BA, Brazil

and more 46 locations

FoCo: Evaluating a Training to Increase Attention and Awareness of Healthcare Professionals

Not Applicable

Completed

Conditions: Attention
Self-compassion

Interventions: Behavioral: FoCo
Behavioral: No intervention

First Posted Date: 2020-04-24

Last Posted Date: 2021-02-11

Lead Sponsor: Hospital Israelita Albert Einstein

Target Recruit Count: 190

Registration Number: NCT04362397

Locations: 🇧🇷
Hospital Israelita Albert Einstein, Sao Paulo, Brazil

Fetoscopic Open Spina Bifida Repair Using the SAFER Technique

Completed

Conditions: Chiari Malformation With Spina Bifida
Myelomeningocele
Meningomyelocele
Chiari Malformation Type 2
Open Spina Bifida

Interventions: Other: Neuropsicomotor developmental test

First Posted Date: 2020-04-22

Last Posted Date: 2020-04-22

Lead Sponsor: Hospital Israelita Albert Einstein

Target Recruit Count: 30

Registration Number: NCT04356703

Locations: 🇧🇷
Hospital Israelita Albert Einstein, Sao Paulo, SP, Brazil

Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)

Phase 3

Completed

Conditions: Coronavirus Infections
Pneumonia, Viral

Interventions: Drug: Hydroxychloroquine
Drug: Hydroxychloroquine + azithromycin

First Posted Date: 2020-03-25

Last Posted Date: 2021-01-20

Lead Sponsor: Hospital Israelita Albert Einstein

Target Recruit Count: 440

Registration Number: NCT04321278

Locations: 🇧🇷
Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul, Brazil
🇧🇷
Hospital de Urgência e Emergência de Rio Branco, Rio Branco, AC, Brazil
🇧🇷
Hospital e Clínica São Roque, Ipiaú, BA, Brazil

and more 54 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy